BioCentury | Jul 13, 2020
Targets & Mechanisms

Verge puts ALS target through COVID-19 paces, leaning on preclinical partners

...target was known, apilimod was acquired by LAM Therapeutics and renamed LAM-002. That company, now dubbed AI Therapeutics Inc....
BioCentury | Feb 8, 2016
Financial News

LAM Therapeutics completes venture financing

LAM Therapeutics , Guilford, Conn. Business: Pulmonary, Cancer Date completed: 2016-02-03 Type: Venture financing Raised: $40 million WIR Staff cancer Pulmonary...
BioCentury | Feb 4, 2016
Financial News

LAM closes $40M financing

LAM Therapeutics (Guilford, Conn.) said it raised $40 million in a venture round from undisclosed investors. The company develops therapeutics for cancer and rare diseases. President and CSO Henri Lichenstein told BioCentury the company uses...
BioCentury | Jun 17, 2013
Financial News

LAM Therapeutics completes venture financing

LAM Therapeutics , Guilford, Conn. Business: Pulmonary Date completed: 6/6/13 Type: Venture financing Raised: Not disclosed Investors: Private investors WIR Staff Pulmonary...
Items per page:
1 - 4 of 4
BioCentury | Jul 13, 2020
Targets & Mechanisms

Verge puts ALS target through COVID-19 paces, leaning on preclinical partners

...target was known, apilimod was acquired by LAM Therapeutics and renamed LAM-002. That company, now dubbed AI Therapeutics Inc....
BioCentury | Feb 8, 2016
Financial News

LAM Therapeutics completes venture financing

LAM Therapeutics , Guilford, Conn. Business: Pulmonary, Cancer Date completed: 2016-02-03 Type: Venture financing Raised: $40 million WIR Staff cancer Pulmonary...
BioCentury | Feb 4, 2016
Financial News

LAM closes $40M financing

LAM Therapeutics (Guilford, Conn.) said it raised $40 million in a venture round from undisclosed investors. The company develops therapeutics for cancer and rare diseases. President and CSO Henri Lichenstein told BioCentury the company uses...
BioCentury | Jun 17, 2013
Financial News

LAM Therapeutics completes venture financing

LAM Therapeutics , Guilford, Conn. Business: Pulmonary Date completed: 6/6/13 Type: Venture financing Raised: Not disclosed Investors: Private investors WIR Staff Pulmonary...
Items per page:
1 - 4 of 4